The oral formulation led to up to 12.2% weight loss over three months, a weaker outcome versus late-stage treatments from Eli ...

Viking's key drug demonstrated excellent body weight reduction data in a phase 2 trial, but its safety and tolerability data ...

Viking Therapeutics' stock drops 40% despite strong Phase 2 weight-loss drug results. See here to know why I remain ultra ...

Viking (NYSE: VIK) stock is down approximately 3% after the cruise line’s second-quarter earnings report. The company ...

Viking Therapeutics said Tuesday its experimental weight-loss pill helped patients lose 12.2% of their body weight in a ...

Viking Therapeutics Inc.’s worst stock drop in nine years has handed traders betting against the company a gain big enough to ...

Viking? Royal Caribbean? Celebrity? What is Dan's favorite cruise line originally appeared on TravelHost. Everyone asks "what ...

Viking Holdings Ltd (NYSE: VIK) shares slipped despite strong Q2 results and positive analyst outlook. Pricing power and ...

Viking Therapeutics Inc. plunged in early trading on Tuesday after its experimental obesity pill disappointed in a mid-stage ...

Viking Therapeutics, Inc.'s obesity drug VK2735 results reveal no clear edge over leading competitors. Click for why this ...

The modern Viking diet emphasizes whole foods over ultraprocessed options, with experts recommending home cooking and ...